Tevogen Bio Holdings Inc. (TVGN)
Healthcare
Biotechnology
7.10 $
+4.9%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Tevogen Bio Holdings Inc. (TVGN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 25.5% of the shares are freely tradable; institutional investors hold 3.6%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
3.6%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
74.4%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
25.5%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
5.3%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
4Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Capital Management, LLC | 0.79 | 33,248 | +0.0 | 03/31/2026 |
| BlackRock Inc | 0.58 | 24,395 | -98.0 | 03/31/2026 |
| Vanguard Group Inc | 0.54 | 1,133,745 | +4.1 | 12/31/2025 |
| Morgan Stanley - Brokerage Accounts | 0.41 | 17,334 | -93.1 | 03/31/2026 |
| Geode Capital Management, LLC | 0.38 | 15,734 | -97.2 | 03/31/2026 |
| Deutsche Bank AG | 0.37 | 15,324 | -91.2 | 03/31/2026 |
| FMR Inc | 0.24 | 10,157 | -90.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Instl Ttl Stk Mkt Idx InstlPls | 0.39 | 16,307 | +0.0 | 04/30/2026 |
| Xtrackers Russell 2000 ETF 1C | 0.36 | 15,176 | -1.0 | 05/29/2026 |
| Vanguard Total Stock Mkt Idx Inv | 0.36 | 15,102 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.